ALLBIRDS INC-CL A (BIRD)

US01675A2087 - Common Stock

6.49  +0.09 (+1.41%)

After market: 6.49 0 (0%)

Fundamental Rating

3

Overall BIRD gets a fundamental rating of 3 out of 10. We evaluated BIRD against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. While BIRD has a great health rating, there are worries on its profitability. BIRD is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BIRD has reported negative net income.
In the past year BIRD has reported a negative cash flow from operations.
In the past 5 years BIRD always reported negative net income.
BIRD had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -56.07%, BIRD is doing worse than 93.88% of the companies in the same industry.
Looking at the Return On Equity, with a value of -97.70%, BIRD is doing worse than 87.76% of the companies in the same industry.
Industry RankSector Rank
ROA -56.07%
ROE -97.7%
ROIC N/A
ROA(3y)-26.66%
ROA(5y)-19.99%
ROE(3y)-41.9%
ROE(5y)-31.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 44.18%, BIRD is not doing good in the industry: 61.22% of the companies in the same industry are doing better.
BIRD's Gross Margin has declined in the last couple of years.
BIRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5Y-4.06%

More info and screens

8

2. Health

2.1 Basic Checks

BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BIRD has been reduced compared to 1 year ago.
The number of shares outstanding for BIRD has been reduced compared to 5 years ago.
There is no outstanding debt for BIRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BIRD has an Altman-Z score of -2.52. This is a bad value and indicates that BIRD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BIRD (-2.52) is worse than 89.80% of its industry peers.
BIRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.52
ROIC/WACCN/A
WACC9.43%

2.3 Liquidity

BIRD has a Current Ratio of 3.39. This indicates that BIRD is financially healthy and has no problem in meeting its short term obligations.
BIRD has a Current ratio of 3.39. This is amongst the best in the industry. BIRD outperforms 89.80% of its industry peers.
BIRD has a Quick Ratio of 2.13. This indicates that BIRD is financially healthy and has no problem in meeting its short term obligations.
BIRD's Quick ratio of 2.13 is amongst the best of the industry. BIRD outperforms 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.39
Quick Ratio 2.13

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.46% over the past year.
BIRD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.67%.
The Revenue has been growing by 68.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)12.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.56%
Revenue 1Y (TTM)-22.67%
Revenue growth 3Y5.03%
Revenue growth 5Y68.35%
Sales Q2Q%-24.88%

3.2 Future

Based on estimates for the next years, BIRD will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.65% on average per year.
The Revenue is expected to grow by 15.43% on average over the next years. This is quite good.
EPS Next Y18.71%
EPS Next 2Y12.41%
EPS Next 3Y13.15%
EPS Next 5Y18.65%
Revenue Next Year-24.98%
Revenue Next 2Y-14.78%
Revenue Next 3Y-7.73%
Revenue Next 5Y15.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BIRD. In the last year negative earnings were reported.
Also next year BIRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BIRD's earnings are expected to grow with 13.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.41%
EPS Next 3Y13.15%

More info and screens

0

5. Dividend

5.1 Amount

BIRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLBIRDS INC-CL A

NASDAQ:BIRD (1/14/2025, 8:26:08 PM)

After market: 6.49 0 (0%)

6.49

+0.09 (+1.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners39.03%
Inst Owner Change0%
Ins Owners1.08%
Ins Owner Change-3.58%
Market Cap51.47M
Analysts48.89
Price Target11.22 (72.88%)
Short Float %13.21%
Short Ratio9.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.07%
Min EPS beat(2)17.38%
Max EPS beat(2)32.77%
EPS beat(4)4
Avg EPS beat(4)23.98%
Min EPS beat(4)17.38%
Max EPS beat(4)32.77%
EPS beat(8)8
Avg EPS beat(8)18.96%
EPS beat(12)10
Avg EPS beat(12)14.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.85%
Min Revenue beat(2)0.11%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-2.66%
Max Revenue beat(4)2.2%
Revenue beat(8)5
Avg Revenue beat(8)-0.56%
Revenue beat(12)7
Avg Revenue beat(12)0.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1984.85%
EPS NY rev (1m)0%
EPS NY rev (3m)4.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-12.08
EYN/A
EPS(NY)-11.05
Fwd EYN/A
FCF(TTM)-7.82
FCFYN/A
OCF(TTM)-7.28
OCFYN/A
SpS25.96
BVpS16.06
TBVpS16.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.07%
ROE -97.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.18%
FCFM N/A
ROA(3y)-26.66%
ROA(5y)-19.99%
ROE(3y)-41.9%
ROE(5y)-31.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5Y-4.06%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.68%
Cap/Sales 2.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.39
Quick Ratio 2.13
Altman-Z -2.52
F-Score4
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)171.98%
Cap/Depr(5y)221.3%
Cap/Sales(3y)7.84%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.56%
EPS Next Y18.71%
EPS Next 2Y12.41%
EPS Next 3Y13.15%
EPS Next 5Y18.65%
Revenue 1Y (TTM)-22.67%
Revenue growth 3Y5.03%
Revenue growth 5Y68.35%
Sales Q2Q%-24.88%
Revenue Next Year-24.98%
Revenue Next 2Y-14.78%
Revenue Next 3Y-7.73%
Revenue Next 5Y15.43%
EBIT growth 1Y11.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.47%
EBIT Next 3Y18.25%
EBIT Next 5Y18.41%
FCF growth 1Y47.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.02%
OCF growth 3YN/A
OCF growth 5YN/A